Percentage of subset participants with grading shifts in hematology and chemistry laboratory assessments;Percentage of subset participants with grading shifts in hematology and chemistry laboratory assessments;GMFR in SARS-CoV-2 S1-binding IgG levels;GMFR in SARS-CoV-2 serum neutralizing titers;SARS-CoV-2 serum neutralizing antibody levels, expressed as GMTs;Percentage of participants reporting local reactions;Percentage of participants reporting systemic events;Percentage of participants reporting adverse events;Percentage of participants reporting serious adverse events;Percentage of subset participants with abnormal hematology and chemistry laboratory values;Percentage of subset participants with abnormal hematology and chemistry laboratory values;Percentage of subset participants with abnormal hematology and chemistry laboratory values;SARS-CoV-2 S1-binding IgG levels, expressed as GMCs;Percentage of subset participants with grading shifts in hematology and chemistry laboratory assessments

Percentage of subset participants with grading shifts in hematology and chemistry laboratory assessments;Percentage of subset participants with grading shifts in hematology and chemistry laboratory assessments;GMFR in SARS-CoV-2 S1-binding IgG levels;GMFR in SARS-CoV-2 serum neutralizing titers;SARS-CoV-2 serum neutralizing antibody levels, expressed as GMTs;Percentage of participants reporting local reactions;Percentage of participants reporting systemic events;Percentage of participants reporting adverse events;Percentage of participants reporting serious adverse events;Percentage of subset participants with abnormal hematology and chemistry laboratory values;Percentage of subset participants with abnormal hematology and chemistry laboratory values;Percentage of subset participants with abnormal hematology and chemistry laboratory values;SARS-CoV-2 S1-binding IgG levels, expressed as GMCs;Percentage of subset participants with grading shifts in hematology and chemistry laboratory assessments